Davis's Drug Guide
lifileucel
General
Pronunciation:
lif-i-loo-sel
Trade Name(s)
- Amtagvi
Ther. Class.
temporary class
autologous gene therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Lifileucel." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580207/7/lifileucel.
Vallerand AHA, Sanoski CAC. Lifileucel. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580207/7/lifileucel. Accessed October 14, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Lifileucel. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580207/7/lifileucel
Vallerand AHA, Sanoski CAC. Lifileucel [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 14]. Available from: https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580207/7/lifileucel.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lifileucel
ID - 3580207
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580207/7/lifileucel
PB - F.A. Davis Company
ET - 20
DB - Harriet Lane
DP - Unbound Medicine
ER -
